United States Pharmacy Automation Market Growth, Demand and Challenges of the Key Industry Players 2032
                     United States Pharmacy 
Automation Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
IMARC Group is  a g lobal  management  consul t ing f i rm that  he lps the wor ld ’s  most  ambi t ious 
changemakers  to create a las t ing impact .  Across the s ix  major  cont inents  and 100+ count r ies ,  we 
work a longside our  bus iness par tners  as one team wi th  a common ambi t ion to achieve unparal le led 
resul ts ,  gain a compet i t ive edge,  and t ransform indust r ies .  IMARC Group excels  in  unders tanding 
i ts  c l ients ’  bus iness pr ior i t ies  and del iver ing ta i lored solut ions that  dr ive meaningfu l  outcomes.  Our 
c l ient  base spans over  3,000 organizat ions in  the pr ivate,  publ ic ,  and soc ia l  sectors ,  ranging f rom 
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of  market  entry  and expansion serv ices.  Our of fer ings inc lude 
thorough market  assessment ,  feas ib i l i ty  s tudies,  company incorporat ion ass is tance,  fac tory  setup 
suppor t ,  regulatory  approvals and l icens ing navigat ion,  branding,  market ing and sales st rategies,  
compet i t ive landscape and benchmark ing analyses,  pr ic ing and cost  research,  and procurement  
research.  These serv ices are des igned to ass is t  companies in  evaluat ing market  oppor tuni t ies ,  
set t ing up new ent i t ies ,  navigat ing regulatory landscapes,  boost ing brand v is ib i l i ty ,  analyz ing 
compet i tors,  and opt imiz ing procurement  s t rategies.
A c c o r d i n g  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  G r o u p ,  t i t l e d  " U n i t e d  S t a t e s  P h a r m a c y  A u t o m a t i o n  
M a r k e t :  I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  G r o w t h ,  O p p o r t u n i t y  a n d  F o r e c a s t  2 0 2 4 -
2 0 3 2 , "  t h e  U n i t e d  S t a t e s  p h a r m a c y  a u t o m a t i o n  m a r k e t  s i z e  i s  p r o j e c t e d  t o  e x h i b i t  a  g r o w t h  
r a t e  ( C A G R )  o f  9 . 0 0 %  d u r i n g  2 0 2 4 - 2 0 3 2 .
Report W i t h  t h e  r i s i n g  v o l u m e  o f  p r e s c r i p t i o n s  d r i v e n  b y  a n  a g i n g  p o p u l a t i o n  a n d  t h e  p r e v a l e n c e  o f  c h r o n i c  d i s e a s e s ,  p h a r m a c i e s  a r e  u n d e r  p r e s s u r e  t o  h a n d l e  a  l a r g e r  w o r k l o a d  w i t h  m i n i m a l  
e r r o r s .  A u t o m a t i o n  t e c h n o l o g i e s ,  s u c h  a s  a u t o m a t e d  d i s p e n s i n g  c a b i n e t s ,  r o b o t i c  p r e s c r i p t i o n  
Highlight and d i s p e n s i n g  s y s t e m s ,  a n d  p h a r m a c y  m a n a g e m e n t  s o f t w a r e ,  a r e  b e i n g  r a p i d l y  a d o p t e d  t o  m e e t  t h e s e  d e m a n d s .  
T h e s e  s y s t e m s  e n h a n c e  t h e  a c c u r a c y  o f  d i s p e n s i n g  m e d i c a t i o n s ,  r e d u c e  h u m a n  e r r o r s ,  a n d  
Description s t r e a m l i n e  w o r k f l o w ,  a l l o w i n g  p h a r m a c i s t s  t o  f o c u s  m o r e  o n  p a t i e n t  c a r e  a n d  l e s s  o n  m a n u a l  t a s k s .  M o r e o v e r ,  t h e  i n t e g r a t i o n  o f  a d v a n c e d  t e c h n o l o g i e s  l i k e  a r t i f i c i a l  i n t e l l i g e n c e  ( A I )  a n d  
m a c h i n e  l e a r n i n g  i n  p h a r m a c y  a u t o m a t i o n  s y s t e m s  i s  f u r t h e r  d r i v i n g  m a r k e t  g r o w t h .  T h e s e  
t e c h n o l o g i e s  e n a b l e  p r e d i c t i v e  a n a l y t i c s ,  i n v e n t o r y  m a n a g e m e n t ,  a n d  p e r s o n a l i z e d  m e d i c a t i o n  
m a n a g e m e n t ,  c o n t r i b u t i n g  t o  i m p r o v e d  o p e r a t i o n a l  e f f i c i e n c y  a n d  p a t i e n t  o u t c o m e s .
R e q u e s t  f o r  a  P D F  s a m p l e  o f  t h i s  r e p o r t :  
h t t p s : / / w w w . i m a r c g r o u p . c o m / u n i t e d - s t a t e s - p h a r m a c y - a u t o m a t i o n - m a r k e t / r e q u e s t s a m p l e
Report Description
Uni t ed  S t a t es  Phar mac y  Aut o ma t i on  M ark e t  T r ends :
Ano t h e r  ke y  f ac t o r  p r o pe l l i ng  t h e  g r o w t h  o f  t he  pha r m ac y  au t om a t ion  m a r ke t  i n  t he  Un i t ed  S t a t es  i s  t he  i n c r eas ing  f ocus  
on  c os t  r educ t i on  and  r e gu la t o r y  co m p l i a nce .  H ea l t h ca r e  p r ov id e r s  a nd  ph a r m ac ies  a r e  c on t i nu a l l y  l o ok ing  f o r  w ays  t o  
r educ e  o pe r a t i ona l  cos t s  wh i l e  m a in t a in ing  h igh  s t an da r d s  o f  ca r e .  A u t om a t ion  sys t em s  h e lp  r educe  l abo r  cos t s ,  m i n im iz e  
m ed ic a t i on  wa s t ag e ,  and  op t i m ize  i nv en t o r y  m anag em e n t ,  l ead i ng  t o  s ign i f i c an t  co s t  s av ings .  Ad d i t i o na l l y ,  t he  s t r i c t  
r egu l a t o r y  env i r o nm e n t  i n  t he  Un i t ed  S t a t es ,  w h ich  m anda t es  acc u r a t e  and  sec u r e  ha nd l i ng  o f  m ed ic a t i ons ,  i s  
encou r ag in g  t h e  ad op t i on  o f  a u t om a t ion  so lu t i ons .  
Thes e  sys t em s  no t  on l y  ensu r e  com p l i an ce  w i t h  r egu la t i on s  l i k e  t he  Dr u g  S upp l y  C ha in  Sec u r i t y  Ac t  ( DSCS A)  bu t  a l s o  
enha nce  da t a  secu r i t y  a nd  t r a ceab i l i t y .  Fu r t he r m or e ,  t he  g r ow in g  t r en d  o f  cen t r a l i ze d  ph a r m acy  se r v i ces  i n  hos p i t a l s  a nd  
hea l t h  s ys t e m s  i s  d r i v i ng  t he  dem an d  f o r  l a r ge - s ca le  au t o m a t i on  so lu t i ons  t ha t  can  m anage  h ig h  v o lum e s  o f  p r esc r i p t i o ns  
w i t h  p r ec i s ion  and  spee d .  A s  a  r e su l t ,  t he  Un i t ed  S t a t es  pha r m a cy  au t om a t ion  m ar k e t  i s  p o i sed  f o r  co n t i n ued  g r ow t h ,  
suppo r t e d  by  t he  d ua l  im pe r a t i ves  o f  e f f i c i e ncy  and  com p l ia nce  i n  a  r ap id l y  evo l v ing  hea l t h ca r e  l and scape .
Vi ew  Repo r t  T O C,  F i g ures  and  T ab l e s :  h t t ps : / / w w w . i mar cgrou p . com / un i t ed - s t a t es - p harm acy- a u t om at i on - m arke t
Product Type Insights:
• Automated Medication Dispensing Systems
• Automated Storage and Retr ieval Systems
• Automated Packaging and Label ing Systems
• Tabletop Tablet Counters
• Others
Report 
Segmentation Application Insights:
• Drug Dispensing and Packaging
• Drug Storage
• Inventory Management
End User Insights:
• Hospita l  Pharmacies
• Retai l  Pharmacies
• Others
Regional Insights:
• Northeast
Report • Midwest
• South
Segmentation • West
• Asteres Inc.
• Capsa Healthcare
• McKesson Corporation
Competitive • Omnicel l  Inc.
• RxSafe LLC
Landscape 
with Key 
Players
How has the United States pharmacy automation market 
performed so far and how will it perform in the coming 
years?
What has been the impact of COVID-19 on the United States 
pharmacy automation market?
What is the breakup of the United States pharmacy 
automation market on the basis of product type?
Key 
What is the breakup of the United States pharmacy 
Questions automation market on the basis of application?
Answered in What is the breakup of the United States pharmacy automation market on the basis of end user?
the Report What are the various stages in the value chain of the United 
States pharmacy automation market? 
What are the key driving factors and challenges in the United 
States pharmacy automation?
What is the structure of the United States pharmacy 
automation market and who are the key players?
What is the degree of competition in the United States 
pharmacy automation market? 
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4    U n i t e d  S t a t e s  P h a r m a c y  A u t o m a t i o n  M a r k e t  -  I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     M a r k e t  D y n a m i c s
    4 . 3     I n d u s t r y  T r e n d s
    4 . 4     C o m p e t i t i v e  I n t e l l i g e n c e
5    U n i t e d  S t a t e s  P h a r m a c y  A u t o m a t i o n  M a r k e t  L a n d s c a p e
    5 . 1     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
    5 . 2     M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6    U n i t e d  S t a t e s  P h a r m a c y  A u t o m a t i o n  M a r k e t  -  B r e a k u p  b y  P r o d u c t  T y p e
    6 . 1     A u t o m a t e d  M e d i c a t i o n  D i s p e n s i n g  S y s t e m s
        6 . 1 . 1  O v e r v i e w
        6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 1 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 2     A u t o m a t e d  S t o r a g e  a n d  R e t r i e v a l  S y s t e m s
        6 . 2 . 1  O v e r v i e w
        6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 2 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
       
    6 . 3     A u t o m a t e d  P a c k a g i n g  a n d  L a b e l i n g  S y s t e m s
        6 . 3 . 1  O v e r v i e w
        6 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 3 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 4     T a b l e t o p  T a b l e t  C o u n t e r s
        6 . 4 . 1  O v e r v i e w
        6 . 4 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 4 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 5     O t h e r s
        6 . 5 . 1  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 5 . 2  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
Table of 7    U n i t e d  S t a t e s  P h a r m a c y  A u t o m a t i o n  M a r k e t  -  B r e a k u p  b y  A p p l i c a t i o n
    7 . 1     D r u g  D i s p e n s i n g  a n d  P a c k a g i n g
        7 . 1 . 1  O v e r v i e w
Contents         7 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )        7 . 1 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    7 . 2     D r u g  S t o r a g e
        7 . 2 . 1  O v e r v i e w
        7 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 2 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    7 . 3     I n v e n t o r y  M a n a g e m e n t
        7 . 3 . 1  O v e r v i e w
        7 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 3 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
8    U n i t e d  S t a t e s  P h a r m a c y  A u t o m a t i o n  M a r k e t  -  B r e a k u p  b y  E n d  
U s e r
    8 . 1     H o s p i t a l  P h a r m a c i e s
        8 . 1 . 1  O v e r v i e w
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /u n i t ed - s ta t es -pha rma c y -a u to m a t
i o n -m a rke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: